Recurring Prostate Cancer- What ADT Treatment Schedule Is Superior?

 One of the many constantly recurring topics that we discuss is over the efficacy of intermittent hormone deprivation therapy (IAD) as opposed to continuous hormone deprivation therapy (CAD). Which therapy is better has been debated for at least ten years. The debate still rages over the question of efficacy, or survival as well as the quality of life (QOL). Often, the debate does not consider whether one therapy might be superior depending upon the individual man’s disease state. A recent study evaluated the efficacy of these two treatment schedules in men with non-metastatic relapsing, locally advanced prostate cancer. The study [...]